Trials / Terminated
TerminatedNCT02893826
Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH
Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Edge Therapeutics Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Safety and Pharmacokinetic study comparing intracisternal EG-1962 to enternal nimopidine in the treatment of aneurysmal subarachnoid hemorrhage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EG-1962 (nimodipine microparticles) | |
| DRUG | Enteral Nimodipine |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-12-01
- Completion
- 2018-03-01
- First posted
- 2016-09-09
- Last updated
- 2018-07-26
Locations
4 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02893826. Inclusion in this directory is not an endorsement.